Alessandra D'Alessandro Selected Research

Alessandra D'Alessandro Research Topics

Disease

6	Inflammation (Inflammations) 01/2021 - 12/2013
2	Diarrhea 03/2018 - 10/2017
2	Esophageal Achalasia (Megaesophagus) 03/2017 - 01/2016
1	Fistula 01/2022
1	Colic (Abdominal Cramps) 01/2022
1	Hypersensitivity (Allergy) 01/2021
1	Dyspepsia (Indigestion) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 05/2018
1	Neuroinflammatory Diseases 03/2018
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2018
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Colonic Neoplasms (Colon Cancer) 08/2016
1	Carcinoma (Carcinomatosis) 06/2016
1	Deglutition Disorders (Dysphagia) 01/2016
1	Colitis 01/2016
1	Pathologic Constriction (Stenosis) 11/2015
1	Esophageal Stenosis (Esophageal Stricture) 11/2015
1	Glioma (Gliomas) 06/2015
1	Melanoma (Melanoma, Malignant) 06/2015
1	Neoplasms (Cancer) 06/2015
1	Shock 12/2013
1	Cholangitis 12/2013
1	Cholestasis 12/2013
1	Choledocholithiasis 12/2013
1	Coronary Disease (Coronary Heart Disease) 06/2012
1	Cardiac Arrhythmias (Arrythmia) 06/2012
1	Necrosis 01/2008
1	Atrial Fibrillation 01/2008

Drug/Important Bio-Agent (IBA)

4	palmidrolIBA 01/2021 - 01/2016
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2018 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 03/2018 - 06/2015
2	PPAR alphaIBA 03/2018 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2016 - 01/2016
1	N 30IBA 01/2022
1	AcidsIBA 01/2021
1	Insulin Lispro (Humalog)FDA Link 05/2018
1	AntidiarrhealsIBA 03/2018
1	NF-kappa B (NF-kB)IBA 03/2018
1	tat Gene Products (tat Protein)IBA 03/2018
1	Trans-Activators (Trans-Acting Factor)IBA 03/2018
1	EnzymesIBA 01/2018
1	EndocannabinoidsIBA 01/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 03/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2017
1	Rifaximin (L 105)FDA Link 08/2016
1	Pregnane X ReceptorIBA 08/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2016
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2016
1	SodiumIBA 01/2016
1	Dextrans (Dextran)FDA Link 01/2016
1	SteroidsIBA 11/2015
1	Calcium-Binding ProteinsIBA 06/2015
1	Pentamidine (NebuPent)FDA LinkGeneric 06/2015
1	PlasticsIBA 12/2013
1	Nicotine FDA Link 06/2012
1	SmokeIBA 06/2012
1	CatecholaminesIBA 06/2012
1	Irbesartan FDA LinkGeneric 01/2008
1	von Willebrand FactorIBA 01/2008
1	Cell Adhesion MoleculesIBA 01/2008
1	Interleukin-6 (Interleukin 6)IBA 01/2008
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2008
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2008
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2008
1	C-Reactive ProteinIBA 01/2008
1	Angiotensin IIIBA 01/2008

Therapy/Procedure

4	Therapeutics 03/2018 - 11/2015
2	Stents 01/2022 - 12/2013
1	Gastrectomy 01/2022
1	Chemoprevention 08/2016
1	Aftercare (After-Treatment) 01/2016
1	Myotomy 01/2016
1	Heller Myotomy 01/2016
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 12/2013
1	Endoscopic Sphincterotomy 12/2013
1	Laser Lithotripsy 12/2013